Literature DB >> 15358961

Novel neuroimaging findings in a patient with cerebral Whipple's disease: a magnetic resonance imaging and positron emission tomography study.

N Galldiks1, L Burghaus, S Vollmar, J Cizek, P Impekoven, A Thomas, A H Jacobs, K Herholz.   

Abstract

The authors report a 43-year-old patient with histopathologically proven cerebral Whipple's disease. Magnetic resonance imaging (MRI) revealed a multilayered left frontal lesion without mass effect, no perifocal brain edema, no contrast enhancement, and a thin shell of fluid signal that presented as an incomplete, open ring. An [11C]methionine positron emission tomography (PET) study showed low uptake below the threshold that is characteristic for brain tumors. In precise co-registration to the MR images, the PET data showed that increased uptake was mainly located in the direct adjacent part of the MRI lesion. The fluid signal on MRI corresponded to the extensive outflow of fluid from the lesion, which was observed during neurosurgical resection, and also to the neuropathological findings. The authors conclude that this cerebral manifestation of Whipple's disease made a unique and hitherto undescribed appearance on MRI; uptake pattern of PET amino acid tracer may help in the preoperative distinction of inflammatory from neoplastic lesions.

Entities:  

Mesh:

Year:  2004        PMID: 15358961     DOI: 10.1177/1051228404267994

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  4 in total

1.  A patient with cerebral Whipple disease with gastric involvement but no gastrointestinal symptoms: a consequence of local protective immunity?

Authors:  Harald Prüss; Juri Katchanov; Rolf Zschenderlein; Christoph Loddenkemper; Thomas Schneider; Verena Moos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-19       Impact factor: 10.154

2.  Neurologic manifestations of Whipple's disease.

Authors:  Mara M Lugassy; Elan D Louis
Journal:  Curr Infect Dis Rep       Date:  2006-06       Impact factor: 3.725

3.  Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas.

Authors:  Norbert Galldiks; Lutz W Kracht; Lothar Burghaus; Anne Thomas; Andreas H Jacobs; Wolf-Dieter Heiss; Karl Herholz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-01       Impact factor: 9.236

4.  [11C]-L-methionine positron emission tomography in the management of children and young adults with brain tumors.

Authors:  Norbert Galldiks; Lutz W Kracht; Frank Berthold; Hrvoje Miletic; Johannes C Klein; Karl Herholz; Andreas H Jacobs; Wolf-Dieter Heiss
Journal:  J Neurooncol       Date:  2009-07-04       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.